Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Pfizer”

A Safety Study of SEA-CD70 in Patients With Myeloid MalignanciesRecruiting
NCT04227847Phase 1Updated Jul 22, 2026
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Myelodysplastic Syndrome · Acute Myeloid Leukemia
United States, Japan, Netherlands
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid TumorsRecruiting
NCT07318805Phase 1Updated Jul 22, 2026
Sponsor: Pfizer
Advanced Breast Cancer · Metastatic Breast Cancer (HR+/ HER2-) · Colorectal Cancer · Metastatic Colorectal Adenocarcinoma
United States
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced CancersRecruiting
NCT07227298Phase 1, Phase 2Updated Jul 22, 2026
Sponsor: Pfizer
Advanced/Metastatic Non-Small Cell Lung Cancer · Carcinoma, Non-Small Cell Lung · Non-Small Cell Lung Cancer
United States, China, France, Germany, Italy +4 more
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)Recruiting
NCT07144280Phase 3Updated Jul 22, 2026
Sponsor: Pfizer
Non-small Cell Carcinoma · Non-Small Cell Lung Cancer Metastatic · Non-Small Cell Lung Carcinoma
United States, Argentina, Australia, Belgium, Brazil +24 more
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or ObesityRecruiting
NCT07595549Phase 3Updated Jul 22, 2026
Sponsor: Pfizer
Obesity · Overweight and/or Obesity · Overweight
United States, Japan
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung CancerRecruiting
NCT07222566Phase 3Updated Jul 22, 2026
Sponsor: Pfizer
Advanced Non-Small Cell Lung Cancer · Non-Small Cell Lung Cancer · Carcinoma, Non-Small-Cell Lung · Carcinoma, Non-Small-Cell Lung (NSCLC)
United States, Argentina, Australia, Brazil, Canada +15 more
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal CancerRecruiting
NCT07222800Phase 3Updated Jul 22, 2026
Sponsor: Pfizer
Intestinal Neoplasms · Gastrointestinal Neoplasms · Digestive System Neoplasms · Neoplasms by Site
United States, Argentina, Australia, Belgium, Brazil +12 more
The SUGAR Study; SBRT and Relugolix) for Prostate CancerRecruiting
NCT06111781Phase 2Updated Jul 21, 2026
Sponsor: Yale University
Prostate Cancer
United States
A Phase II Trial of Avelumab in Patients With Recurrent or Progressive OsteosarcomaCompleted
NCT03006848Phase 2Updated Jul 21, 2026
Sponsor: St. Jude Children's Research Hospital
Osteosarcoma
United States
Study Evaluating 13-valent Pneumococcal Conjugate Vaccine (13vPnC) in Healthy Children Aged 15 Months to 17 YearsCompleted
NCT00761631Phase 3Updated Jul 21, 2026
Sponsor: Pfizer
Healthy Subjects
United States
Palbociclib and Pembrolizumab In Central Nervous System MetastasesRecruiting
NCT02896335Phase 2Updated Jul 21, 2026
Sponsor: Massachusetts General Hospital
Metastatic Malignant Neoplasm to Brain · Recurrent Brain Metastases · Progressive Brain Metastases
United States
A Study to Understand How a Study Medicine Called PF-07328948 is Absorbed and Processed in the Body of Healthy Male AdultsActive Not Recruiting
NCT07508228Phase 1Updated Jul 20, 2026
Sponsor: Pfizer
Healthy
United States
PAveMenT: Palbociclib and Avelumab in Metastatic AR+ Triple Negative Breast CancerRecruiting
NCT04360941Phase 1Updated Jul 20, 2026
Sponsor: Royal Marsden NHS Foundation Trust
Triple Negative Breast Cancer · Locally Advanced Breast Cancer · Recurrent Breast Cancer · Metastatic Breast Cancer
United Kingdom
The AVIATOR Study: Trastuzumab and Vinorelbine With Avelumab OR Avelumab & Utomilumab in Advanced HER2+ Breast CancerActive Not Recruiting
NCT03414658Phase 2Updated Jul 20, 2026
Sponsor: Adrienne G. Waks
Breast Cancer
United States
Zavegepant Intranasal Spray for the Acute Treatment of Episodic Cluster HeadacheNot Yet Recruiting
NCT07714369Phase 2Updated Jul 20, 2026
Sponsor: The University of Texas Health Science Center, Houston
Cluster Headache
United States
A Study to Evaluate the Efficacy and Safety of PF-06480605 in Adults With Moderate to Severe Ulcerative ColitisCompleted
NCT04090411Phase 2Updated Jul 17, 2026
Sponsor: Hoffmann-La Roche
Moderate to Severe Ulcerative Colitis
United States, Australia, Belgium, Bulgaria, Colombia +18 more
Reward Sensitivity and Pharmacotherapy for Smoking CessationActive Not Recruiting
NCT02162849Phase 4Updated Jul 16, 2026
Sponsor: M.D. Anderson Cancer Center
Tobacco Use Cessation
United States
CPX-351 and Glasdegib for Newly Diagnosed Acute Myelogenous Leukemia With MDS Related Changes or Therapy-related Acute Myeloid LeukemiaActive Not Recruiting
NCT04231851Phase 2Updated Jul 16, 2026
Sponsor: University of California, Irvine
Acute Myelogenous Leukemia (AML) Due to Therapy · Acute Myeloid Leukemia With Myelodysplasia-Related Changes
United States
Encorafenib, Binimetinib and Cetuximab in Subjects With Previously Untreated BRAF-mutant ColoRectal CancerCompleted
NCT03693170Phase 2Updated Jul 16, 2026
Sponsor: Pierre Fabre Medicament
BRAF V600E-mutant Metastatic Colorectal Cancer
United States, Austria, Belgium, France, Italy +4 more
Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and LymphomaRecruiting
NCT06533748Phase 2Updated Jul 16, 2026
Sponsor: St. Jude Children's Research Hospital
Acute Lymphoblastic Leukemia · Lymphoblastic Lymphoma
United States
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast CancerRecruiting
NCT03424005Phase 1, Phase 2Updated Jul 15, 2026
Sponsor: Hoffmann-La Roche
Metastatic Breast Cancer
United States, Australia, France, Germany, Israel +4 more
A Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With Muscle-invasive Bladder Cancer Keep Their BladderRecruiting
NCT07475806Phase 2Updated Jul 15, 2026
Sponsor: Astellas Pharma Global Development, Inc.
Muscle-invasive Bladder Cancer
United States, Japan, South Korea
Ritlecitinib for Cicatricial AlopeciaCompleted
NCT05549934Phase 2Updated Jul 15, 2026
Sponsor: Emma Guttman
Cicatricial Alopecia
United States
A Study to Learn About the Study Medicine PF-07220060 Together With Letrozole Compared to Letrozole Alone in Women Post MenopauseCompleted
NCT06465368Phase 2Updated Jul 15, 2026
Sponsor: Pfizer
Breast Cancer
United States, Australia, Belgium, France, Germany +8 more
Study to Evaluate Sacituzumab Govitecan in Combination With Talazoparib in Patients With Metastatic Breast Cancer.Active Not Recruiting
NCT04039230Phase 1, Phase 2Updated Jul 14, 2026
Sponsor: Massachusetts General Hospital
Breast Cancer
United States

Previous page Next page